臨床試驗

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

NCT：NCT05064540 · RECRUITING

NCT IDNCT05064540

狀態RECRUITING

開始日期2021-09-20

SponsorEndologix (INDUSTRY)

First posted2021-10-01

Last updated2026-09-09

簡要摘要

Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。